F711 in Montana. Pick another state for the same tag.
Against expectation — 2025
Montana cites F711 more often than its own record predicts
Versus expected share1.27×
1.27 times the share F711 takes of citations nationally.
Share of Montana citations0.16%
Of every deficiency written in Montana in 2025, this is the portion that was F711.
Montana0.16%
National0.12%
Share of all citations that were F711.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Montana surveyors wrote
F711 findings written in Montana, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedJune 4, 2026
Based on interviews and record review, the facility failed to ensure all physician orders were signed and dated for 1 (#29) of 34 sampled and supplemental residents. This deficient practice placed residents at risk of medication errors. Findings include:Review of resident #29's Psychiatry Follow-up Visit, dated 4/27/26, showed resident #29's risperidone medication was discontinued after a gradual dose reduction was completed, and the resident did not display aggression in the last three weeks. Review of resident #29's EHR medication list, dated 6/3/26, showed resident #29 was actively receiving risperidone 0.125 mg beginning 3/7/26. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction